Exclusive: As Sweeping Policy Framework Takes Shape, MNCs May Be Forced To Slash Prices Of Patented Drugs In India
This article was originally published in PharmAsia News
Executive Summary
A newly drafted policy structure, obtained by PharmAsia News, could change pricing dynamics for patented drugs in India.